UnitedHealth Group yesterday sought to extricate itself from a stock options backdating scandal as the largest US health insurer restated earnings by more than $1.5bn over the last 12 years.

UnitedHealth is one of more than 200 companies under investigation by US regulators for altering the date of options to provide more favourable prices to key executives.